ADAM KOELSCH: Open Payments
NPI 1558559518 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 20 payments from 9 companies in 2025. Trend: 2023 $878 · 2024 $893 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $163 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Corium, LLC | 4 | $86 |
| Lundbeck LLC | 3 | $55 |
| Alkermes, Inc. | 2 | $50 |
| Indivior Inc. | 1 | $27 |
| Bausch Health US, LLC | 1 | $25 |
| Orexo US, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: CAPLYTA, Auvelity, Azstarys, REXULTI, LYBALVI, SUBLOCADE, APLENZIN, Zubsolv.
Industry payments across AZ — which companies pay providers there.
